GlassScriptPhysician profile
Ariel L Stein
NPI 1356897474
$2,618.69
in general payments reported to CMS, 2019-2025
10 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $350 · 2022: $506 · 2023: $1,091 · 2024: $250 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $482.60 | 2021-2025 | Jakafi, Monjuvi |
| E.R. Squibb & Sons, L.L.C. | $449.60 | 2023 | Reblozyl, Pomalyst, Onureg |
| Genmab U.S., INC. | $443.86 | 2023-2025 | Epkinly |
| Genzyme Corporation | $394.96 | 2021-2023 | |
| Kite Pharma, INC. | $240.65 | 2022 | |
| Janssen Scientific Affairs, LLC | $141.39 | 2023 | Imbruvica |
| Genentech, INC. | $138.62 | 2023 | Lunsumio, Columvi |
| Beone Medicines USA, INC. | $125.00 | 2025 | Brukinsa |
| Celgene Corporation | $101.44 | 2021 | |
| Abbvie INC. | $100.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.